Boundary Capital Partners has announced it is raising a £10m fund to invest further into British technology and life science businesses. It will be the fourth in the successful line of Boundary Capital funds. The AngelPlus fund is an evergreen fund designed to give investors access to a portfolio of early stage technology and life…

Two industry leaders have been appointed partners at early-stage venture capital firm Boundary Capital. Dr Adrian Parton MBE and Grant Hawthorne are both key influencers in their respective fields of biotechnology and investment. The appointments mark an increase in UK investments made by Boundary Capital in 2015 and the launch of their new SEIS fund…

Boundary Capital has joined other UK angels and VCs to pump $2.15 million into Cambridge-born Desktop Genetics (DTG). The Investment will accelerate development of the startup’s DESKGEN genome editing software platform. The platform aims to revolutionise the way genetic researchers carry out gene editing experiments. The cash comes from a syndicate of VCs and angel…

Boundary Capital Partners LLP is authorised and regulated by the Financial Conduct Authority.
Boundary Capital Partners LLP Reg: OC387581 VAT: 204012873
Registered office: 35 Kingsland Road, London, England, E2 8AA

STAY CONNECTED WITH US: